Clinicopathologic analysis of <scp>TAFRO</scp> syndrome demonstrates a distinct subtype of <scp>HHV</scp>‐8‐negative multicentric Castleman disease
2015 · American Journal of Hematology · 273 citations
https://doi.org/10.1002/ajh.24242
C
Christopher S. Nabel
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
61
Papers
4.0K
Citations
22
h-index
28
i10-index
Christopher S. Nabel is an academic researcher from Massachusetts General Hospital. The author has contributed to research in topics: Epigenetics and DNA Methylation & Viral-associated cancers and disorders & RNA modifications and cancer. The author has an h-index of 22, co-authored 52 publications.
ORCID: 0000-0001-6515-8579Papers by this author
worksNucleotide imbalance decouples cell growth from cell proliferation
2022 · Nature Cell Biology · 191 citations
https://doi.org/10.1038/s41556-022-00965-1
Inhibition of ENT1 relieves intracellular adenosine-mediated T cell suppression in cancer
2025 · Nature Immunology · 19 citations
https://doi.org/10.1038/s41590-025-02153-3
Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability
2024 · eLife · 15 citations
https://doi.org/10.7554/elife.95652
Histone Deacetylase 6 Inhibition Exploits Selective Metabolic Vulnerabilities in LKB1 Mutant, KRAS Driven NSCLC
2023 · Journal of Thoracic Oncology · 10 citations
https://doi.org/10.1016/j.jtho.2023.03.014
LKB1 regulates JNK-dependent stress signaling and apoptotic dependency of KRAS-mutant lung cancers
2025 · Nature Communications · 6 citations
https://doi.org/10.1038/s41467-025-58753-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat